- CSR Summary Not Available
- NCT00236665
- Primary Citation
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment531% Female72%% White100%
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-OBHT-001Data PartnerJohnson & JohnsonCondition StudiedHypertension, ObesityMean/Median Age (Years)50
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0580 : Developing approaches to accelerate clinical trials using real world data (RWD) from electronic health records (EHR)
- 2023-5534 : Quality tolerance limit and duplicated patient investigation in clinical trials
- 2020-4276 : Psychiatric Symptoms as Adverse Events of Topiramate Therapy: Systematic Review and Meta-Analysis